Summary
In vitro practically all common antibiotics except cephalosporins are active against nearly all natural isolates ofListeria monocytogenes; the therapeutic efficacy of antibiotic treatment is, however, rather limited, since up to 30% listeriosis patients will succumb to this infection. At least one reason for this lowin vivo efficiency is the intracellular habitat ofL. monocytogenes. In animal experiments ampicillin or amoxicillin, respectively, are still the most active drugs. In addition, rifampicin also has pronounced protective activity. Coumermycin, which unfortunately cannot be given to humans, is the most reliable drug in animals.
Zusammenfassung
Obwohl praktisch alle Listerienin vitro empfindlich gegenüber den üblichen Antibiotika — außer den Cephalosporinen — sind, ist der therapeutische Erfolg recht gering, denn bis zu 30% der behandelten Patienten sterben an dieser Infektion. Dies liegt zum Teil daran, daß eben zu einem erheblichen Teil sich diese Bakterien intrazellulär vermehren. Anhand von Tierversuchen läßt sich zeigen, daß Ampicillin bzw. Amoxicillin immer noch die höchste Effektivität bei der Listeriose besitzt. Auch Rifampicin hat eine auffallend gute Aktivität. Coumermycin, das im Tiermodell die beste Wirksamkeit besitzt, kann leider nicht für die Anwendung am Menschen zugelassen werden.
Similar content being viewed by others
References
Goebel, W., Chakraborty, T., Domann, E., Köhler, S., Kuhn, M., Leimeister-Wächter, M., Sokolovic, S., Wuenscher, M.: Studies on the pathogenicity ofListeria monocytogenes. Infection, this issue, S 195–S 197.
Hof, H.: Intracellular microorganisms: a particular problem for chemotherapy. Infection, this issue, S 193–S 194.
Espaze, E. P., Reynaud, A. E. Antibiotic susceptibilities ofListeria: in vitro studies. Infection 16 (Suppl. 2) (1988) 160- 164.
Weingärtner, L., Ortel, S. Zur Behandlung der Listeriose mit Ampicillin. Dtsch. Med. Wochenschr. 92 (1967) 1098–1104.
Marget, W., Seeliger, H. P. R. Listeria monocytogenes infectionstherapeutic possibilities and problems. Infection 16 (Suppl. 2) (1988) 175–177.
Nieman, R., E., Lorber, B. Listeriosis in adults: a changing pattern. Rev. Inf. Dis. 2 (1980) 207–227.
Heymer, B., Wirsing von König, C. H., Finger, H., Hof, H., Emmerling, P. Histomorphology of experimental listeriosis. Infection 16 (Suppl. 2) (1988) 106–111.
Reiss, H. J., Potel, J., Krebs, H. Granulomatosis infantiseptica. Z. gesamte Inn. Med. 6 (1951) 451–457.
Cossel, L., Mahnke, P. F. Electron-microscopical hepatic findings in experimental listeriosis. Beitr. Path. Anat. 138 (1968) 65–95.
North, R. J. The relative importance of blood monocytes and fixed macrophages to the expression of cell-mediated immunity to infection. J. Exp. Med. 132 (1970) 521–534.
Mackaness, G. B. Cellular resistance to infection. J. Exp. Med. 116 (1962) 381–406.
Tilney, L. G., Portnoy, D. A. Actin filaments and the growth, movement, and spread of the intracellular bacterial parasite,Listeria monocytogenes. J. Cell Biol. 109 (1989) 1597–1608.
Mielke, M. E. A., Niedobitek, G., Stein, H., Hahn, H. Acquired resistance toListeria monocytogenes is mediated by Lyt-2+ T-cells independently of the influx of monocytes into granulomatous lesions. J. Exp. Med. 170 (1989) 589–594.
Brown, K. N., Percival, A. Penetration of antimicrobials into tissue culture cells and leukocytes. Scand. J. Infect. Dis., Suppl. 14 (1978) 251–260.
Bakker-Woudenberg, I. A. J. M., Lokerse, A. F., Vink-van den Berg, J. C., Roerdink, F. H. Liposome-encapsulated ampicillin againstListeria monocytogenes in vivo andin vitro. Infection 16 (Suppl. 2) (1988) 165–170.
Fattal, E., Rojas, J., Andremont, A., Covreur, P.: Efficacité comparée de nanoparticules et de liposomes chargés en ampicilline dans le traitement de la listériose et de la salmonellose expérimentales chez la souris. In: Proc. 5th Int. Conf. Pharm. Technol. Paris, 1989, APGI (Vol. III), Chatenay Malabry 1989, pp. 72–79.
Hof, H., Waldenmeier, G. Therapy of experimental listeriosis — an evaluation of different antibiotics. Infection 16 (Suppl. 2) (1988) 171–174.
Hof, H., Gückel, H. Lack of synergism of ampicillin and gentamicin in experimental listeriosis. Infection 15 (1987) 40–41.
Kihlström, E. Infection of cells withSalmonella typhimurium. Infect. Immun. 17 (1977) 290–295.
Trouet, A., Tulkens, P. Intracellular penetration and distribution of antibiotics: the basis for an improved chemotherapy of intracellular infections. In:Ninet, L., Bost, P. E., Bouanchaud, D. H., Florent, J.: The future of antibiotherapy and antibiotic research. Academic Press, London 1981, pp. 337–346.
Hoeprich, P. D. Infection due toListeria monocytogenes. Medicine (Baltimore) 37 (1958) 143–160.
Poyart-Salmeron, C., Carlier, C., Trieu-Cuot, P., Courtin, A.-L., Courvalin, P. Transferable plasmid-mediated antibiotic resistance inListeria monocytogenes. Lancet 335 (1990) 1422–1426.
Strauss, R., Hof., H., Ströder, J. Antibiotikatherapie im abwehrgeschwächten Wirt — dargestellt am Modell der Listeriose der Maus. Die Wirkung von Erythromycin, anderen Makrolidantibiotika und verwandten Antibiotika. ZAC 3 (1985) 107–114.
Van der Auwera, P., Matsumoto, T., Husson, M. Intraphagocytic penetration of antibiotics. J. Antimicrob. Chemother. 22 (1988) 185–192.
Metz, P., Hof, H., Kathariou, S. Inhibitory effect of tetracycline and doxycycline on resistance of mice to infection with a tetracycline-resistant strain ofListeria monocytogenes. Int. J. Immunopharmac. 10 (1988) 519–524.
Hof, H. Treatment of experimental listeriosis by CI 934, a new quinolone. J. Antimicrob. Chemother. 25 (1990) 121–126.
Berner, R., Hof, H. Therapeutic activity of teicoplanin on experimental listeriosis compared with that of vancomycin and ampicillin. Zbl. Bakt. Hyg. A 268 (1988) 50–56.
Hof, H. Die Wirksamkeit von Daptomycin (LY 146032) auf Listerienin vitro undin vivo. ZAC 7 (1989) 35–38.
Pascual, A., Tsukayama, D., Kovarik, J., Gekker, G., Peterson, P. Uptake and activity of rifapentine in human peritoneal macrophages and polymorphonuclear leukocytes. Eur. J. Clin. Microbiol. 6 (1987) 152–157.
Kawaler, B., Hof, H. Murine model for therapy of listeriosis in the compromised host. IV. Cotrimoxazole. Chemotherapy 31 (1985) 366–371.
Hof, H., Emmerling, P. Murine model for therapy of listeriosis in the compromised host. III. The effect of rifampicin. Chemotherapy 30 (1984) 125–130.
Scheld, W. M. Evaluation of rifampicin and other antibiotics againstListeria monocytogenes in vitro andin vivo. Rev. Inf. Dis. 5 (Suppl. 3) (1983) 593–599.
Hof, H. The effect of coumermycin on experimental listeriosis. J. Infect. 13 (1986) 17–23.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hof, H. Therapeutic activities of antibiotics in listeriosis. Infection 19 (Suppl 4), S229–S233 (1991). https://doi.org/10.1007/BF01644039
Issue Date:
DOI: https://doi.org/10.1007/BF01644039